These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6163954)
1. Progress towards a unified theory of the mechanisms of carcinogenesis: role of cell cycle restriction points. Hull LA Med Hypotheses; 1981 Feb; 7(2):187-200. PubMed ID: 6163954 [TBL] [Abstract][Full Text] [Related]
2. Oncogenes and transmembrane cell signaling. Chiarugi V; Ruggiero M; Porciatti F Cancer Invest; 1987; 5(3):215-29. PubMed ID: 2820554 [No Abstract] [Full Text] [Related]
3. [Chalone(s) and epidermal growth factors]. Pruniéras M; Delescluse C Ann Dermatol Venereol; 1982; 109(10):889-97. PubMed ID: 6303190 [No Abstract] [Full Text] [Related]
4. From growth arrest to growth suppression. Philipson L; Sorrentino V J Cell Biochem; 1991 Jun; 46(2):95-101. PubMed ID: 1717501 [TBL] [Abstract][Full Text] [Related]
5. Interferons and growth factors viewed as two families of hormones with opposing actions. Inglot AD Tex Rep Biol Med; 1981-1982; 41():402-10. PubMed ID: 6184831 [No Abstract] [Full Text] [Related]
6. Role of cyclic nucleotides in growth control. Pastan IH; Johnson GS; Anderson WB Annu Rev Biochem; 1975; 44():491-522. PubMed ID: 166606 [No Abstract] [Full Text] [Related]
7. Progress towards a unified theory of the mechanisms of carcinogenesis, III: Circumvention of proliferation controls. Hull LA Med Hypotheses; 1982 Jan; 8(1):85-93. PubMed ID: 7062861 [TBL] [Abstract][Full Text] [Related]
8. Mutual interactions between p53 and growth factors in cancer. Asschert JG; Vellenga E; De Jong S; de Vries EG Anticancer Res; 1998; 18(3A):1713-25. PubMed ID: 9673395 [TBL] [Abstract][Full Text] [Related]
9. [Thyroid growth factors]. Pawlikowski M; Lewiński A Endokrynol Pol; 1987; 38(5):351-9. PubMed ID: 2842126 [No Abstract] [Full Text] [Related]
11. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation. Rybalkin SD; Bornfeldt KE Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733 [No Abstract] [Full Text] [Related]
12. Growth factors, growth inhibitors and cell cycle control (review). Sorrentino V Anticancer Res; 1989; 9(6):1925-35. PubMed ID: 2697193 [TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotides promote monocyte differentiation toward a DC-SIGN+ (CD209) intermediate cell and impair differentiation into dendritic cells. Giordano D; Magaletti DM; Clark EA; Beavo JA J Immunol; 2003 Dec; 171(12):6421-30. PubMed ID: 14662841 [TBL] [Abstract][Full Text] [Related]
14. Cyclic-AMP inhibits cell growth and negatively interacts with platelet membrane glycoprotein expression on the Dami human megakaryoblastic cell line. Vittet D; Duperray C; Chevillard C J Cell Physiol; 1995 Jun; 163(3):645-55. PubMed ID: 7539815 [TBL] [Abstract][Full Text] [Related]
15. Action of growth factors in the cell cycle. Rudland PS; Jimenez de Asua L Biochim Biophys Acta; 1979 Feb; 560(1):91-133. PubMed ID: 216405 [No Abstract] [Full Text] [Related]
16. [Cyclic purine nucleotides, 3',5'-AMP and 3',5'-GMP, as factors regulating the proliferation and differentiation of hemopoeitic cells]. Fedorov NA Usp Sovrem Biol; 1975; 79(2):225-40. PubMed ID: 169644 [No Abstract] [Full Text] [Related]
17. Turning off growth signals in tumours: a new approach to cancer chemotherapy. Denny WA N Z Med J; 2001 Feb; 114(1125):47-8. PubMed ID: 11277478 [No Abstract] [Full Text] [Related]
18. Cyclic AMP, calcium and control of cell growth. Ralph RK FEBS Lett; 1983 Sep; 161(1):1-8. PubMed ID: 6309571 [TBL] [Abstract][Full Text] [Related]
19. Autocrine growth factors and cancer. Sporn MB; Roberts AB Nature; 1985 Feb 28-Mar 6; 313(6005):745-7. PubMed ID: 3883191 [TBL] [Abstract][Full Text] [Related]
20. [Interferons as non-classical hormones interacting with growth factors]. Inglot AD Postepy Biochem; 1987; 33(2-3):151-64. PubMed ID: 2453865 [No Abstract] [Full Text] [Related] [Next] [New Search]